Leukocare AG’s Post

Innovation in drug delivery has always started with one simple question: what do patients need most? In her latest article, Fran DeGrazio, executive editor of Drug Delivery Leader, reflects on 40 years of progress — from traditional vial-and-stopper systems to today’s advanced biologics, precision medicines, and combination therapies that are reshaping patient care. Fran explores how the next generation of drug delivery innovations, including nanoparticles, ADCs, and targeted delivery systems, are helping make precision medicine a reality, and what it will take for biopharma organizations to stay regulatorily and operationally ready for this new era. Continue reading: https://lnkd.in/eSCNrcrq 📩 For more drug formulation and delivery insights, subscribe to the Drug Delivery Leader e-newsletter: https://lnkd.in/en_7JcHW

Samsung Biologics’ analytical development strategy accelerates timelines by applying core platform methods across a wide range of ADC molecules. Streamlining method transfer through optimized project initiation, Samsung Biologics meets clients’ expedited analytical timeline needs without compromising performance. ☑️ Applicability to diverse ADC molecules and linker-payloads ☑️ Test scope encompassing both “platform-able” and less “platform-able” methods ☑️ Cell-based assay method development shortened by 1.5 months Explore more in the poster by Jae ook Kim, Ph.D. and team: https://lnkd.in/eCgM-w6d #ADC #AnalyticalDevelopment #CDMO #SamsungBiologics

📢New Publication Alert! We’re excited to share that our latest innovation, Planova™ FG1, is featured in BioProcess International! This article highlights how FG1 sets a new benchmark in virus removal filtration—combining high throughput with robust virus removability. One of the key takeaways: FG1 demonstrates stable filtration performance even at 30 mg/mL antibody concentration, a condition increasingly common in modern bioprocessing. Key features of FG1 include: ✅ Exceptional water flux (1,220 LMH @ 49.7 psi) ✅ Strong resistance to process interruptions (maintains performance after 120-minute pause) Explore how FG1 supports biopharmaceutical safety and efficiency in the full article: https://ow.ly/V3At50XnAtr #PlanovaFG1 #AsahiKaseiBioprocess #Bioprocessing

💡 Did you know 80% of the world’s population lives in emerging countries — yet they have 20x less access to biologics? We’re expanding access to life-saving treatments by offering biosimilar medicines that are more affordable and accessible. Learn how we’re making a difference: https://abbo.tt/3LjhhEM

It’s Global Biosimilars Week ✨ the perfect time to spotlight how biosimilars are helping expand access to life-saving treatments for those who need them most, especially in emerging countries.

Healthcare value shouldn’t be defined by geography or income level. Making biologic-level treatment more accessible through biosimilars is not only a scientific advancement — it is a meaningful step toward fair, dignified, and inclusive global health.

Analyzing glycans in complex biologics is challenging. Even small variations can affect efficacy, safety and consistency. Avantor® helps simplify this complexity with reliable chromatography solutions. Avantor ACE® glycan columns deliver high resolution, stability and reproducibility — supporting precise glycan analysis for confident biopharma development. Read more:

As the field of cell therapy continues its rapid transition toward clinical applications, the global biopharmaceutical industry is increasingly emphasizing the shift to animal-free (xeno-free) manufacturing. Ensuring process stability and product quality under evolving regulatory expectations has become a central challenge for cell therapy manufacturers.   On November 6, Integrated-Bio and the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA) co-hosted a focused seminar titled: “Animal-Free Cell Manufacturing: Challenges and Evolving Regulatory Landscape.”   We were honored to welcome distinguished experts who shared insights from regulatory, process, and quality perspectives. The event fostered inspiring discussions and cross-sector exchange, reflecting the industry's strong momentum toward safer and more sustainable cell manufacturing practices.   Integrated-Bio remains committed to partnering with global leaders to advance animal-free, standardized, and sustainable manufacturing solutions —empowering the next generation of regenerative medicine.     #捷昇 #捷昇生物 #InVitria  #CellTherapy  #AnimalFree #RegenerativeMedicine  #Biomanufacturing  #CellProcessing

🔬 𝗛𝗼𝘄 𝗶𝘀 𝘁𝗵𝗲 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗼𝘂𝗿 𝗰𝗹𝗶𝗲𝗻𝘁𝘀? 🔬 As a CDMO specialized in biologics, we focus on empowering our clients to bring life-changing therapies to patients faster with quality, flexibility and scientific excellence at every step ⚗️ From plasmid DNA to proteins, we decode biologics production so our partners can focus on what matters most: advancing science and improving lives ❤️ Learn how we do it: https://lnkd.in/eN8FmfXh #53Biologics #CDMO #BiopharmaIndustry #Innovation #Partnership

The biopharmaceutical landscape is evolving, with diverse therapeutic modalities requiring advanced analytical tools. The Thermo Scientific Orbitrap Ascend BioPharma Tribrid Mass Spectrometer is designed to meet these challenges with its innovative features and comprehensive characterization capabilities. Discover how this powerful instrument can accelerate your research. Read our blog to learn more! http://spr.ly/6040AxESj #OrbitrapAscend #Biopharma #PTM #Oligonucleotides #Therapeutics